Clinical Trial Update: Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating dual boosted protease inhibitor regimens without additional antiretroviral therapy in HIV-1 infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 2 | Status: COMPLETED